Basit öğe kaydını göster

dc.contributor.authorLeblebicioglu, H
dc.contributor.authorEsen, S
dc.date.accessioned2022-02-18T11:25:24Z
dc.date.available2022-02-18T11:25:24Z
dc.date.issued2003
dc.identifier.citationLeblebicioglu H., Esen S., "Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study", JOURNAL OF HOSPITAL INFECTION, cilt.53, sa.3, ss.207-210, 2003
dc.identifier.issn0195-6701
dc.identifier.otherav_f599b222-ae94-4f8d-8478-072be95cacb7
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/181154
dc.identifier.urihttps://doi.org/10.1053/jhin.2002.1362
dc.description.abstractHospital-acquired urinary tract infection (UTI) is the most common infection acquired in hospitals. The aim of the study was to determine the prevalence of UTIs in Turkey. A nationwide one day point-prevalence survey was conducted. Centers for Diseases Control and Prevention (CDC) standard definitions for nosocomial UTIs were used. Data were collected by detailed uniform questionnaires for each patient with UTI. A total of 13 269 patients were investigated, the number of patients observed in each hospital varied from 21 to 1329 patients, an average of 458 patients per prevalence study per hospital. The overall prevalence of UTI was 1.7%. Fifty-eight (26.1%) of the patients had sepsis or septic shock. Twenty-five (11.3%) patients had culture-proven bloodstream infection. Over 60% (65.3%) of urinary tract infections were associated with urinary catheters. Overall, 78.4% of UTIs were culture-proven. Escherichia coli (32.4%) was the most common reported pathogen, followed by Klebsiella spp. (17.0%), Candidaspp. (12.8%),Pseudomonas aeruginosa.(11.7%) and enterococci 8.5%. The prevalence of ampicillin-resistant E. coli was 23.9% and accounted for 73.8% of all E. coli isolated from UTI 8.2%, and 24.6% of E. coli were resistant to quinolones and ceftriaxone, respectively. There were no resistance to carbapenems in E. colt but 6.25, 40.6, 59.4% of klebsiella spp. were resistant to carbapenems, quinolones and ceftriaxone, respectively. The results of this first national point-prevalence study offers a reliable measure of the prevalence of nosocomial UTIs at hospitals in Turkey and provides a baseline for future studies which will enable the monitoring of trends over time. C 2003 The Hospital Infection Society
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectGeneral Immunology and Microbiology
dc.subjectImmunology
dc.subjectSafety Research
dc.subjectGeneral Social Sciences
dc.subjectHealth (social science)
dc.subjectPublic Health, Environmental and Occupational Health
dc.subjectOccupational Therapy
dc.subjectEpidemiology
dc.subjectInfectious Diseases
dc.subjectSocial Sciences & Humanities
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectSosyal ve Beşeri Bilimler
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectİmmünoloji
dc.subjectBULAŞICI HASTALIKLAR
dc.subjectSosyal Bilimler (SOC)
dc.subjectSosyal Bilimler Genel
dc.subjectKAMU, ÇEVRE VE İŞ SAĞLIĞI
dc.subjectSosyoloji
dc.titleHospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study
dc.typeMakale
dc.relation.journalJOURNAL OF HOSPITAL INFECTION
dc.contributor.department, ,
dc.identifier.volume53
dc.identifier.issue3
dc.identifier.startpage207
dc.identifier.endpage210
dc.contributor.firstauthorID3372297


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster